Based on the evidence that GHRH antagonists were able to suppress experimental tumor growth and that a subset of EC expressed receptors for GHRH, the application of powerful new GHRH antagonists could be useful for the treatment of this type of malignancy. The gene discussed is GHRH; the disease is neoplasm.